TMC Life Sciences Berhad (TMCLS) is one of the fastest growing healthcare groups in Malaysia. It has been listed on the Main Market of Bursa Malaysia Securities Berhad since 2005. The Group aims to be the “Pan-Asia Preferred Healthcare System of Choice” delivering quality, value-based care to its patients and customers. TMCLS has embarked on a major expansion plan, with significant additional capacity and capabilities projected to come on stream by year 2020.
The plan includes the expansion of its flagship hospital, Thomson Hospital Kota Damansara to a 600-bed hospital with additional specialist centres, operating theatre, a Cancer Centre and a multi-storey carpark. A new integrated medical hub – Thomson Iskandar – will be developed in the proposed Vantage Bay Healthcare City in bustling Johor Bahru. Located just off the Causeway linking Johor and Singapore, Thomson Iskandar will house a 500-bed tertiary hospital, specialist medical suites and related health and wellness facilities.